Stoke Therapeutics, Inc. (STOK) closed the last trading session at $13.27, gaining 16.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.14 indicates a 66.8% upside potential.The average comprises seven short-term price targets ranging from a low of $14 to a high of $35, with a standard deviation of $7.38. While the lowest estimate indicates an increase of 5.5% from the current ...